Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus-Reference-Cited by-同舟云学术

Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus

Published:2017-11 Issue:46 Volume:35 Page:6336-6344
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Bertran Kateri,Balzli Charles,Lee Dong-Hun,Suarez David L.,Kapczynski Darrell R.,Swayne David E.

Funder

Agricultural Research Service

U.S. Department of Agriculture

APHIS

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference58 articles.

1. World Organisation for Animal Health (OIE). Influenza: cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. ; 2017.

2. OIE. Update on highly pathogenic avian influenza in animals (type H5 and H7). ; 2017.

3. The global nature of avian influenza;Swayne,2016

4. Avian influenza vaccination in North America: strategies and difficulties;Suarez;Dev Biol (Basel),2006

5. Avian influenza control strategies;Sims,2016

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens;PLOS ONE;2024-07-16

2. Highly pathogenic influenza H5: risks of a new pandemic strain developing;Journal Infectology;2024-01-10

3. Efficacy of recombinant H5 vaccines delivered in ovo or day of age in commercial broilers against the 2015 U.S. H5N2 clade 2.3.4.4c highly pathogenic avian Influenza virus;Virology Journal;2023-12-15

4. Poultry Vaccine Technology Platforms;Avian Diseases;2023-12-12

5. Efficacy of inactivated and RNA particle vaccines against a North American Clade 2.3.4.4b H5 highly pathogenic avian influenza virus in chickens;Vaccine;2023-11